On April 14, 2021 Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) reported that the publication of the Full Year 2020 financial results, which had been scheduled for April 20th, 2021, will be postponed until April 30th, 2021 (Press release, Vivoryon Therapeutics, APR 14, 2021, View Source [SID1234578010]). The postponement is due to unexpected delays in the finalization of Vivoryon’s financial statements related to its transition into a Dutch N.V. corporation. The Company’s Board of Directors made the decision to move the reporting date to ensure completeness of the filing and in compliance with the laws of the Netherlands.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!